期刊文献+

骨肉瘤中抑癌基因p33/ING1 mRNA的表达及意义 被引量:1

The expression and significance of tumour suppressor gene p33/ING1 in osteosarcoma.
下载PDF
导出
摘要 目的研究骨肉瘤中抑癌基因p33/ING1 mRNA的表达与临床病理特征的关系。方法应用RT-PCR技术对40例骨肉瘤标本及其相邻的正常软组织、2例骨肉瘤细胞株(OS732和SaOS2)和1例原代培养的骨膜细胞中ING1基因的表达进行研究。结果在40例骨肉瘤标本中,27例(67.5%)检测到p33/ING1 mRNA较其相邻的正常软组织高表达。p33/ING1 mRNA高表达患者肿瘤转移发生率明显高于低表达的患者,两者比较差异有显著意义(t=2.52,P<0.05);而在临床分期方面差异无显著意义。2例骨肉瘤细胞株与原代培养的骨膜细胞相比较,1例(OS732)检测到p33/ING1 mRNA的低表达,1例(SaOS2)检测到p33/INC1 mRNA的高表达。结论抑癌基因p33/ING1mRNA的高表达在骨肉瘤的发生发展中起到一定作用,且与肿瘤转移有关。 Backgound & Objective p33/ING1 is a new tumor suppressive gene (TSG); though p33/ING1 expression were detected in some tumors, yet its function is still unknown. Reports about its function in osteosarcoma tissue were lacking in home and foreign literatures. This experimental study focused at the expression of tumour suppressor gene INGlmRNA in osteosar-comas and its relationship with the clinical - pathological features. Methods Expression of p33/INGl in 40 cases of osteosarcoma with matched normal soft tissues; two osteosarcoma cell lines and one periosteum cell line of primary culture were compared using RT-PCR.Results In RT - PCR analysis, p33/ING1mRNA high expression was detected in 27 of 40(67.5% )osteosarcoma specimens. The rate of metastasis was also high in patients with high expression of p33/INGl than those with low expression; and there was significant statistical difference (t = 2.52, P < 0.05) , however, the clinical manifestation showed no significant difference. Comparison with periosteum cell of primary culture, one osteosarcoma cell line (SaOS2) showed high expession. Conclusion High expression of p33/ING1mRNA possibly indicates p33/ING1 having function of osteosarcoma suppressor and it might be closely related with the metastasis.
出处 《中国骨肿瘤骨病》 2002年第4期230-232,共3页 Chinse Journal Of Bone Tumor And Bone Disease
基金 国家自然科学基金项目(30070766)
关键词 基因 抑制 肿瘤 基因表达 骨肉瘤 逆转录聚合酶链反应 Genes, Suppresor, tumor Gene expression. Osteosarcoma Reverse transcriptase Polymerase chain reaction
  • 相关文献

参考文献10

  • 1[1]Garkavtsev I,Kazarov A,Gudkov A,et al. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation. J Nat Genet, 1996,14:415 - 420. 被引量:1
  • 2[2]Toyama T, Iwase H, Watson P, et al. Suppression of ING1 expression in sporadic breast cancer. Oncogene, 1999; 18: 5187 - 5193. 被引量:1
  • 3[3]Garkavtsev I,Riabowol K.Extension of the replicative life span of human diploid fibroblasts by inhibition of the p33ING1 candidate tumor suppressor. Mol Cell Biol 1997,17:2014- 2019. 被引量:1
  • 4[4]Wong H, Anderson WD, Cheng T, et al. Monitoring mRNA Expression by Polymerase Chain Reaction: The "Primer - Dropping" Method. Anal Biochem, 1994,223:251 - 258. 被引量:1
  • 5[5]Garkavtsev I, Demetrick D, Riabowol K, et al. Cellular localization and chromosome mapping of a novel candidate tumor suppressor gene(ING1).Cytogenet Cell Genet, 1997,76:176 - 178. 被引量:1
  • 6[6]Zeremski M, Horrigan SK, Grigorian IA, et al. Localization of the candidate tumor suppressor gene ING1 to human chromosome 13q34. Somat Cell Mol Genet, 1997,23: 233 - 236. 被引量:1
  • 7[7]Gunduz M, Ouchida M, Fukushima K, et al. Genomic structure of the human ING1 gene and tumor- specific mutations detected in head and neck squamous cell carcinomas. Cancer Res, 2000,60: 3143 - 3146. 被引量:1
  • 8[8]Zeremski M, Hill JE, Kwek SS, et al. Structure and regulation of the mouse ing1 gene. Three alternative transcripts encode two phd finger proteins that have opposite effects on p53 function. J Biol Chem, 1999,274:32172 - 32181. 被引量:1
  • 9[9]Loewith R, Meijer M, Lees Miller SP, et al. Three yeast proteins related to the human candidate tumor suppressor p33(ING1 )are associated with histone acetyltransferase activities. Mol Cell Biol 2000; 20: 3807 - 3816. 被引量:1
  • 10[10]Saito A, Furukawa T, Fukushige S, et al. P24/ING1 - ALT1 and p47/ING1 - ALT2, distinct alternative transcripts of p33/ING1. J Hum Genet,2000;45:177 - 181. 被引量:1

同被引文献14

  • 1章烨,王雅杰,姜斌,薛春燕,王梅,李平,顾军.ING1b基因蛋白在乳腺癌组织的表达及临床意义[J].临床肿瘤学杂志,2004,9(5):452-455. 被引量:4
  • 2王自强,周燕虹,蔡志民,余佩武.抑癌基因ING1在大肠癌中的表达与突变(英文)[J].中国临床康复,2005,9(22):262-264. 被引量:2
  • 3史本涛,贺大林.ING1基因与肿瘤关系的研究进展[J].肿瘤防治杂志,2005,12(22):1751-1753. 被引量:4
  • 4Garkavtsev I,Grigorian I A,Ossovskaya V S,et al.The Candidate Tumour Suppressor P33(ING1) Cooperates with P53 in Cell Growth Control[J].Nature,1998,391:295-298. 被引量:1
  • 5[德]赫尔曼尼克.国际抗癌联盟肿瘤TNM分期图谱[M].4版.杨勇,译.北京:科学出版社,2002:203-204. 被引量:1
  • 6Wooster R,Neuhausen S L,Mangion J,et al.Localization of a Breast Cancer Susceptibility Gene,BRCA2,to Chromosome 13q12~13[J].Science,1994,265:2088-2090. 被引量:1
  • 7Nouman G S,Anderson J J.Downregulation of Nuclear Expression of the P33 ING1b Inhibitor of Growth Protein in Invasive Carcinoma of the Breast[J].J Clin Pathol,2003,56:507-511. 被引量:1
  • 8Gasco M,Shami S,Crook T.The P53 Pathway in Brest Cancer[J].Breast Cancer Res,2002,4:70-76. 被引量:1
  • 9Jager D,Stockert E,Scanlan M J,et al.Cancer-testis Antigens and ING1 Tumor Suppressor Gene Product are Breast Cancer Antigens:Characterization of Tissue-specific ING1 Transcripts and a Homologue Gene[J].Cancer Res,1999,59:6197-6204. 被引量:1
  • 10Cheung K J,Bush J A,Jia W,et al.Expression of the Novel Tumour Suppressor P33(ING1) is in Dependent of P53[J].Br J Cancer,2000,83:1468-1472. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部